Author

S. Rellick

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. C. Pirkey· 1 shared A. Fernandez· 1 shared D. J. Klinke· 1 shared D. Piktel· 1 shared J. Hollander· 1 shared K. Martin· 1 shared L. Gibson· 1 shared P. Saralkar· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. C. Pirkey

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell Communication Network factor 4 promotes tumor-induced immunosuppression in melanoma

A. Fernandez, W. Deng, S. L. McLaughlin, A. C. Pirkey, S. Rellick, D. J. Klinke

This study shows that CCN4 promotes immunosuppression in melanoma by reducing CD8+ T cells and increasing MDSCs, and that its removal enhances immune checkpoint therapy effectiveness.

bioRxiv · Feb 23, 2021Cancer Biology

Targeting the dysfunctional mitochondrial respiration in drug resistant B-cell acute lymphoblastic leukemia

R. R. Nair, D. Piktel, P. Thomas, Q. Hathaway, S. Rellick, P. Saralkar, K. Martin, W. J. Geldenhuys, J. Hollander, L. Gibson

This study identifies mitochondrial respiration dysfunction in drug-resistant ALL cells and shows that pyrvinium pamoate (PP) effectively targets this pathway, with enhanced bioavailability and specificity for leukemic cells.

bioRxiv · Apr 1, 2019 · PreprintCancer Biology